Dokter Oelbrandt Lore SRL
Dokter Oelbrandt Lore reported total assets of 207,318 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026).
The score of Dokter Oelbrandt Lore shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +512 % Total assets +338 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dokter Oelbrandt Lore's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 14 Jul 2023
Dokter Oelbrandt Lore's financial analysis
- Solvency97.5%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dokter Oelbrandt Lore
Dokter Oelbrandt Lore's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0775.983.766
- VAT number
- BE0775983766
- Peppol
- Registered · 0208:0775983766 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Oct 2021
- Registered office
- 2811 Mechelen
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- General medical practice activities (NACE 86210)
Dokter Oelbrandt Lore (SRL) has been based in Mechelen since 2021, active in: general medical practice activities. For 2025, it reports a net profit of 80,235 € and equity of 202,210 €; its revenue is not published. Its solvency stands at 97.5%, above the median of its sector (72.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dokter Oelbrandt Lore
Companies in the same business, of comparable size and area, outside its group.
- Dr. Eveline Vercammen General medical practice activities Putte · balance sheet 205,180 €
- Dr. Dorine Boeckx General medical practice activities Boom · balance sheet 195,930 €
- Docteur Boudart Orthopedie General medical practice activities Messancy · balance sheet 209,310 €
- Mondovits General medical practice activities Forest · balance sheet 188,023 €
- Bruno Pornel Consulting General medical practice activities Uccle · balance sheet 241,357 €
- DR. L. DALEWYN, sport- en algemene geneeskunde General medical practice activities Nazareth-De Pinte · balance sheet 207,116 €
- Cabinet Docteur Caroline Glacet General medical practice activities Courcelles · balance sheet 210,207 €
- Calumeth General medical practice activities Liège · balance sheet 212,262 €
Frequently asked questions about Dokter Oelbrandt Lore
What is the revenue of Dokter Oelbrandt Lore?
Dokter Oelbrandt Lore files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dokter Oelbrandt Lore?
In Belgium, the VAT number is the company number prefixed with BE: BE0775983766 for Dokter Oelbrandt Lore, if the company is VAT-registered. Its company number (CBE) is 0775.983.766.
Where is the registered office of Dokter Oelbrandt Lore?
According to the CBE register, the registered office of Dokter Oelbrandt Lore is in 2811 Mechelen.
What is the equity of Dokter Oelbrandt Lore?
At the close of the 2025 financial year, the equity of Dokter Oelbrandt Lore amounts to 202,210 €, a solvency of 97.5% of total assets.
Who manages Dokter Oelbrandt Lore?
The register lists 1 active mandates at Dokter Oelbrandt Lore. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dokter Oelbrandt Lore
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →